Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-27
2007-02-27
Seaman, Margaret D. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S510000
Reexamination Certificate
active
11063626
ABSTRACT:
Texanes having a heterosubstituted acetate substituent at C(7), a hydroxy substitutent at C(10), and a range of C(2), C(9), C(14), and side chain substituents.
REFERENCES:
patent: 4960790 (1990-10-01), Stella et al.
patent: 5175315 (1992-12-01), Holton
patent: 5227400 (1993-07-01), Holton et al.
patent: 5243045 (1993-09-01), Holton et al.
patent: 5283253 (1994-02-01), Holton et al.
patent: 5350866 (1994-09-01), Holton et al.
patent: 5430160 (1995-07-01), Holton
patent: 5567614 (1996-10-01), Patel et al.
patent: 5614645 (1997-03-01), Kingston et al.
patent: 5714513 (1998-02-01), Holton et al.
patent: 5721268 (1998-02-01), Holton et al.
patent: 5767297 (1998-06-01), Mandai et al.
patent: 5780653 (1998-07-01), Tao et al.
patent: 5811452 (1998-09-01), Ojima et al.
patent: 5879929 (1999-03-01), Patel
patent: 5912264 (1999-06-01), Wittman et al.
patent: 5939561 (1999-08-01), Bourzat et al.
patent: 6136988 (2000-10-01), Murray et al.
patent: 6673833 (2004-01-01), Holton
patent: 0 534 709 (1993-03-01), None
patent: 0 558 959 (1993-09-01), None
patent: 0 629 701 (1994-12-01), None
patent: 0 882 732 (1998-12-01), None
patent: 212 577 (1993-02-01), None
patent: 09-241293 (1997-09-01), None
patent: WO 93/18018 (1993-09-01), None
patent: 9417050 (1994-04-01), None
patent: 94/21250 (1994-09-01), None
patent: WO 96/13495 (1996-05-01), None
patent: WO 97/09979 (1997-03-01), None
patent: WO 97/42181 (1997-11-01), None
patent: WO 99/09021 (1999-02-01), None
patent: WO 01/57013 (2001-08-01), None
Gueritte-Voegelein et al. “Relationships between the Structure of Taxol Analogues and Their Antimitotic Activity”,Journal of Medicinal Chemistry, (1991), pp. 992-998, vol. 34:3.
Kant et al. “A Chemoselective Approach to Functionalize the C-10 Position of 10-Deacetylbaccatin III. Synthesis and Biological Properties of Novel C-10 Taxol Analogues”,Tetrahedron Letters, (1994), pp. 5543-5546, vol. 35:30.
Kingston et al. “The Chemistry of Taxol, A Clinically Useful Anticancer Agent”,Journal of Natural Products, (1990), pp. 1-12, vol. 53:1.
Mellado et al. “Preparation and Biological Activity of Taxol Acetates”,Biochemical and Biophysical Research Communications, (1984), pp. 329-336, vol. 124:2.
Samaranayake et al. “Modified Taxols. 5. Reaction of Taxol with Electrophilic Reagents and Preparation of a Rearranged Taxol Derivative with Tubulin Assembly Activity”,J. Org. Chem., (1991), pp. 5114-5119, vol. 56:17.
Straubinger et al. “Pharmacology and Antitumor Effect of Novel Placlitaxel Formulations” Chapter 8,Taxane Anticancer Agents, (1994), pp. 111-123.
Suffness “Chapter 32. Taxol: From Discovery to Therapeutic Use”,Annual Reports in Medicinal Chemistry, (1993), pp. 305-314, vol. 28.
Hungarian Patent Office, Novelty Search Report for Application No. P02 00651, dated Aug. 29, 2002.
International Search Report from analogous PCT application No. PCT/US01/03600 dated Jun. 7, 2001.
Journal of Tianjin University, (2000), pp. 51-55, vol. 33:1.
FSU Research Foundation, Inc.
Rahmani Niloofar
Seaman Margaret D.
Senniger Powers
LandOfFree
Taxanes having a C7 heterosubstituted acetate substituent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Taxanes having a C7 heterosubstituted acetate substituent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Taxanes having a C7 heterosubstituted acetate substituent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3831159